Logo image of CCL-B.CA

CCL INDUSTRIES INC - CL B (CCL-B.CA) Stock Fundamental Analysis

Canada - TSX:CCL-B - CA1249003098 - Common Stock

75.62 CAD
-0.2 (-0.26%)
Last: 10/14/2025, 7:00:00 PM
Fundamental Rating

6

CCL-B gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 9 industry peers in the Containers & Packaging industry. CCL-B gets an excellent profitability rating and is at the same time showing great financial health properties. CCL-B is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year CCL-B was profitable.
CCL-B had a positive operating cash flow in the past year.
CCL-B had positive earnings in each of the past 5 years.
Each year in the past 5 years CCL-B had a positive operating cash flow.
CCL-B.CA Yearly Net Income VS EBIT VS OCF VS FCFCCL-B.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

1.2 Ratios

The Return On Assets of CCL-B (7.80%) is better than 88.89% of its industry peers.
CCL-B has a better Return On Equity (14.72%) than 100.00% of its industry peers.
CCL-B has a better Return On Invested Capital (9.70%) than 100.00% of its industry peers.
CCL-B had an Average Return On Invested Capital over the past 3 years of 9.32%. This is in line with the industry average of 8.13%.
The 3 year average ROIC (9.32%) for CCL-B is below the current ROIC(9.70%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 7.8%
ROE 14.72%
ROIC 9.7%
ROA(3y)7.23%
ROA(5y)7.35%
ROE(3y)14.01%
ROE(5y)14.83%
ROIC(3y)9.32%
ROIC(5y)9.53%
CCL-B.CA Yearly ROA, ROE, ROICCCL-B.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

CCL-B has a better Profit Margin (10.58%) than 88.89% of its industry peers.
CCL-B's Profit Margin has improved in the last couple of years.
CCL-B has a Operating Margin of 14.92%. This is amongst the best in the industry. CCL-B outperforms 88.89% of its industry peers.
In the last couple of years the Operating Margin of CCL-B has remained more or less at the same level.
With a Gross Margin value of 29.82%, CCL-B perfoms like the industry average, outperforming 55.56% of the companies in the same industry.
In the last couple of years the Gross Margin of CCL-B has remained more or less at the same level.
Industry RankSector Rank
OM 14.92%
PM (TTM) 10.58%
GM 29.82%
OM growth 3Y0.47%
OM growth 5Y1.18%
PM growth 3Y3.65%
PM growth 5Y5.35%
GM growth 3Y2.04%
GM growth 5Y0.75%
CCL-B.CA Yearly Profit, Operating, Gross MarginsCCL-B.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CCL-B is still creating some value.
Compared to 1 year ago, CCL-B has less shares outstanding
CCL-B has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, CCL-B has an improved debt to assets ratio.
CCL-B.CA Yearly Shares OutstandingCCL-B.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
CCL-B.CA Yearly Total Debt VS Total AssetsCCL-B.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

CCL-B has an Altman-Z score of 3.61. This indicates that CCL-B is financially healthy and has little risk of bankruptcy at the moment.
CCL-B's Altman-Z score of 3.61 is fine compared to the rest of the industry. CCL-B outperforms 66.67% of its industry peers.
CCL-B has a debt to FCF ratio of 3.44. This is a good value and a sign of high solvency as CCL-B would need 3.44 years to pay back of all of its debts.
CCL-B has a Debt to FCF ratio (3.44) which is in line with its industry peers.
CCL-B has a Debt/Equity ratio of 0.47. This is a healthy value indicating a solid balance between debt and equity.
CCL-B has a Debt to Equity ratio of 0.47. This is comparable to the rest of the industry: CCL-B outperforms 44.44% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 3.44
Altman-Z 3.61
ROIC/WACC1.27
WACC7.64%
CCL-B.CA Yearly LT Debt VS Equity VS FCFCCL-B.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.3 Liquidity

A Current Ratio of 2.24 indicates that CCL-B has no problem at all paying its short term obligations.
With a decent Current ratio value of 2.24, CCL-B is doing good in the industry, outperforming 66.67% of the companies in the same industry.
A Quick Ratio of 1.67 indicates that CCL-B should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.67, CCL-B is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.24
Quick Ratio 1.67
CCL-B.CA Yearly Current Assets VS Current LiabilitesCCL-B.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 3.72% over the past year.
The Earnings Per Share has been growing by 10.99% on average over the past years. This is quite good.
The Revenue has been growing slightly by 7.90% in the past year.
Measured over the past years, CCL-B shows a small growth in Revenue. The Revenue has been growing by 6.37% on average per year.
EPS 1Y (TTM)3.72%
EPS 3Y11.84%
EPS 5Y10.99%
EPS Q2Q%-21.94%
Revenue 1Y (TTM)7.9%
Revenue growth 3Y8.12%
Revenue growth 5Y6.37%
Sales Q2Q%4.82%

3.2 Future

The Earnings Per Share is expected to grow by 5.12% on average over the next years.
CCL-B is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.31% yearly.
EPS Next Y1.5%
EPS Next 2Y2.9%
EPS Next 3Y5.12%
EPS Next 5YN/A
Revenue Next Year5.82%
Revenue Next 2Y4.61%
Revenue Next 3Y5.31%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CCL-B.CA Yearly Revenue VS EstimatesCCL-B.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B
CCL-B.CA Yearly EPS VS EstimatesCCL-B.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 16.96, the valuation of CCL-B can be described as correct.
CCL-B's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 27.49. CCL-B is valued slightly cheaper when compared to this.
The Price/Forward Earnings ratio is 15.20, which indicates a correct valuation of CCL-B.
Based on the Price/Forward Earnings ratio, CCL-B is valued a bit more expensive than the industry average as 66.67% of the companies are valued more cheaply.
When comparing the Price/Forward Earnings ratio of CCL-B to the average of the S&P500 Index (22.99), we can say CCL-B is valued slightly cheaper.
Industry RankSector Rank
PE 16.96
Fwd PE 15.2
CCL-B.CA Price Earnings VS Forward Price EarningsCCL-B.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

CCL-B's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. CCL-B is more expensive than 66.67% of the companies in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as CCL-B.
Industry RankSector Rank
P/FCF 17.46
EV/EBITDA 9.47
CCL-B.CA Per share dataCCL-B.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of CCL-B may justify a higher PE ratio.
PEG (NY)11.28
PEG (5Y)1.54
EPS Next 2Y2.9%
EPS Next 3Y5.12%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.67%, CCL-B has a reasonable but not impressive dividend return.
CCL-B's Dividend Yield is comparable with the industry average which is at 3.10.
CCL-B's Dividend Yield is slightly below the S&P500 average, which is at 2.43.
Industry RankSector Rank
Dividend Yield 1.67%

5.2 History

The dividend of CCL-B is nicely growing with an annual growth rate of 11.36%!
CCL-B has been paying a dividend for at least 10 years, so it has a reliable track record.
CCL-B has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)11.36%
Div Incr Years23
Div Non Decr Years34
CCL-B.CA Yearly Dividends per shareCCL-B.CA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

27.13% of the earnings are spent on dividend by CCL-B. This is a low number and sustainable payout ratio.
The dividend of CCL-B is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP27.13%
EPS Next 2Y2.9%
EPS Next 3Y5.12%
CCL-B.CA Yearly Income VS Free CF VS DividendCCL-B.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
CCL-B.CA Dividend Payout.CCL-B.CA Dividend Payout, showing the Payout Ratio.CCL-B.CA Dividend Payout.PayoutRetained Earnings

CCL INDUSTRIES INC - CL B

TSX:CCL-B (10/14/2025, 7:00:00 PM)

75.62

-0.2 (-0.26%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryContainers & Packaging
Earnings (Last)08-13 2025-08-13/amc
Earnings (Next)11-05 2025-11-05
Inst Owners39.94%
Inst Owner ChangeN/A
Ins Owners1.91%
Ins Owner ChangeN/A
Market Cap13.19B
Analysts83.16
Price Target94.55 (25.03%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.67%
Yearly Dividend1.16
Dividend Growth(5Y)11.36%
DP27.13%
Div Incr Years23
Div Non Decr Years34
Ex-Date09-15 2025-09-15 (0.32)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.18%
Min EPS beat(2)2.15%
Max EPS beat(2)4.21%
EPS beat(4)2
Avg EPS beat(4)-0.12%
Min EPS beat(4)-5.47%
Max EPS beat(4)4.21%
EPS beat(8)4
Avg EPS beat(8)3.16%
EPS beat(12)5
Avg EPS beat(12)1.6%
EPS beat(16)8
Avg EPS beat(16)1.77%
Revenue beat(2)0
Avg Revenue beat(2)-1.34%
Min Revenue beat(2)-1.75%
Max Revenue beat(2)-0.94%
Revenue beat(4)0
Avg Revenue beat(4)-1.16%
Min Revenue beat(4)-1.87%
Max Revenue beat(4)-0.08%
Revenue beat(8)1
Avg Revenue beat(8)-1.7%
Revenue beat(12)1
Avg Revenue beat(12)-1.97%
Revenue beat(16)5
Avg Revenue beat(16)-1.23%
PT rev (1m)0%
PT rev (3m)1.53%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.48%
EPS NY rev (1m)0.31%
EPS NY rev (3m)2.34%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.4%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.6%
Valuation
Industry RankSector Rank
PE 16.96
Fwd PE 15.2
P/S 1.76
P/FCF 17.46
P/OCF 11.73
P/B 2.45
P/tB 7.57
EV/EBITDA 9.47
EPS(TTM)4.46
EY5.9%
EPS(NY)4.98
Fwd EY6.58%
FCF(TTM)4.33
FCFY5.73%
OCF(TTM)6.45
OCFY8.53%
SpS42.91
BVpS30.84
TBVpS9.99
PEG (NY)11.28
PEG (5Y)1.54
Profitability
Industry RankSector Rank
ROA 7.8%
ROE 14.72%
ROCE 12.89%
ROIC 9.7%
ROICexc 10.91%
ROICexgc 20.67%
OM 14.92%
PM (TTM) 10.58%
GM 29.82%
FCFM 10.09%
ROA(3y)7.23%
ROA(5y)7.35%
ROE(3y)14.01%
ROE(5y)14.83%
ROIC(3y)9.32%
ROIC(5y)9.53%
ROICexc(3y)10.42%
ROICexc(5y)10.66%
ROICexgc(3y)20.67%
ROICexgc(5y)21.9%
ROCE(3y)12.39%
ROCE(5y)12.67%
ROICexcg growth 3Y-4.22%
ROICexcg growth 5Y-2.39%
ROICexc growth 3Y-1.48%
ROICexc growth 5Y-0.08%
OM growth 3Y0.47%
OM growth 5Y1.18%
PM growth 3Y3.65%
PM growth 5Y5.35%
GM growth 3Y2.04%
GM growth 5Y0.75%
F-Score8
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 3.44
Debt/EBITDA 1.63
Cap/Depr 82.22%
Cap/Sales 4.93%
Interest Coverage 19.62
Cash Conversion 71.84%
Profit Quality 95.38%
Current Ratio 2.24
Quick Ratio 1.67
Altman-Z 3.61
F-Score8
WACC7.64%
ROIC/WACC1.27
Cap/Depr(3y)114.57%
Cap/Depr(5y)103.99%
Cap/Sales(3y)6.78%
Cap/Sales(5y)6.27%
Profit Quality(3y)87.06%
Profit Quality(5y)92.08%
High Growth Momentum
Growth
EPS 1Y (TTM)3.72%
EPS 3Y11.84%
EPS 5Y10.99%
EPS Q2Q%-21.94%
EPS Next Y1.5%
EPS Next 2Y2.9%
EPS Next 3Y5.12%
EPS Next 5YN/A
Revenue 1Y (TTM)7.9%
Revenue growth 3Y8.12%
Revenue growth 5Y6.37%
Sales Q2Q%4.82%
Revenue Next Year5.82%
Revenue Next 2Y4.61%
Revenue Next 3Y5.31%
Revenue Next 5YN/A
EBIT growth 1Y10.18%
EBIT growth 3Y8.62%
EBIT growth 5Y7.62%
EBIT Next Year43.67%
EBIT Next 3Y15.74%
EBIT Next 5YN/A
FCF growth 1Y54.07%
FCF growth 3Y5.34%
FCF growth 5Y6.76%
OCF growth 1Y11.94%
OCF growth 3Y8.25%
OCF growth 5Y6.42%